लोड हो रहा है...

Remyelinating Pharmacotherapies in Multiple Sclerosis

We have witnessed major successes in the development of effective immunomodulatory therapies capable of reducing adaptive immune-mediated myelin damage in MS over the last 30 years. However, until it is possible to prevent MS or initiate treatment before it has already caused lesions there is a need...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Neurotherapeutics
मुख्य लेखकों: Bove, Riley M., Green, Ari J
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer US 2017
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722779/
https://ncbi.nlm.nih.gov/pubmed/28948533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0577-0
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!